PAS
ABBV icon

Partnervest Advisory Services’s AbbVie ABBV Stock Holding History

Partnervest Advisory Services’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$340K Buy
3,880
+234
+6% +$22K 0.11% 158
2020
Q2 		$358K Buy
3,646
+300
+9% +$26.4K 0.14% 126
2020
Q1 		$255K Sell
3,346
-378
-10% -$32.2K 0.11% 149
2019
Q4 		$330K Sell
3,724
-940
-20% -$78K 0.12% 128
2019
Q3 		$353K Buy
4,664
+730
+19% +$50K 0.13% 143
2019
Q2 		$286K Buy
3,934
+120
+3% +$9.43K 0.11% 152
2019
Q1 		$307K Sell
3,814
-4,054
-52% -$332K 0.13% 144
2018
Q4 		$725K Sell
7,868
-1,381
-15% -$121K 0.35% 67
2018
Q3 		$875K Buy
9,249
+753
+9% +$71.4K 0.35% 62
2018
Q2 		$787K Buy
8,496
+1,063
+14% +$104K 0.36% 57
2018
Q1 		$704K Sell
7,433
-374
-5% -$41.1K 0.34% 65
2017
Q4 		$755K Sell
7,807
-154
-2% -$14.5K 0.37% 58
2017
Q3 		$707K Sell
7,961
-2,552
-24% -$194K 0.34% 64
2017
Q2 		$762K Sell
10,513
-35
-0.3% -$2.35K 0.34% 64
2017
Q1 		$687K Buy
10,548
+616
+6% +$38.7K 0.31% 68
2016
Q4 		$622K Sell
9,932
-747
-7% -$45.6K 0.29% 74
2016
Q3 		$674K Buy
10,679
+661
+7% +$42.8K 0.32% 72
2016
Q2 		$620K Buy
10,018
+781
+8% +$47.6K 0.31% 71
2016
Q1 		$528K Buy
9,237
+1,420
+18% +$79.1K 0.28% 77
2015
Q4 		$463K Buy
7,817
+138
+2% +$7.95K 0.26% 85
2015
Q3 		$418K Sell
7,679
-3,923
-34% -$255K 0.24% 84
2015
Q2 		$780K Buy
11,602
+841
+8% +$54.9K 0.39% 47
2015
Q1 		$630K Buy
+10,761
New +$650K 0.33% 54
2014
Q3 		– Sell
-2,580
Closed -$146K – 155
2014
Q2 		$146K Buy
2,580
+35
+1% +$1.84K 0.07% 192
2014
Q1 		$131K Sell
2,545
-150
-6% -$7.58K 0.06% 204
2013
Q4 		$142K Sell
2,695
-365
-12% -$17.9K 0.07% 180
2013
Q3 		$137K Sell
3,060
-985
-24% -$43.7K 0.07% 158
2013
Q2 		$167K Buy
+4,045
New +$177K 0.08% 113

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Partnervest Advisory Services's ABBV Position: Q3 2020 in Review

Partnervest Advisory Services increased its AbbVie (ABBV) stake by 6.4% in Q3 2020, buying an estimated $22K and bringing the position to 3,880 shares worth $340K. The position accounts for 0.11% of the portfolio, ranked #158.

Partnervest Advisory Services first reported a position in ABBV in Q2 2013 and has held it in 28 quarters since. The position peaked at $875K in Q3 2018. 2,366 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

  • Partnervest Advisory Services held 3,880 shares of AbbVie worth $340K as of Q3 2020.
  • Partnervest Advisory Services bought 234 AbbVie shares in Q3 2020, an estimated $22K.
  • AbbVie made up 0.11% of Partnervest Advisory Services's portfolio in Q3 2020, its #158 holding.
  • Partnervest Advisory Services first reported a position in AbbVie in Q2 2013 and has held it in 28 quarters since.
  • Partnervest Advisory Services's AbbVie position peaked at $875K in Q3 2018.
  • 2,366 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on Partnervest Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.